Drug Shortage Report for DILTIAZEM HYDROCHLORIDE INJECTION

Last updated on 2023-09-02 History
Report ID 189684
Drug Identification Number 02514095
Brand name DILTIAZEM HYDROCHLORIDE INJECTION
Common or Proper name Diltiazem Hydrochloride Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 x 10 mL vial / fiole
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-05-26
Estimated end date
Actual end date 2023-09-01
Shortage status Resolved
Updated date 2023-09-02
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v25 2023-09-02 English Compare
v24 2023-09-01 French Compare
v23 2023-09-01 English Compare
v22 2023-09-01 French Compare
v21 2023-09-01 English Compare
v20 2023-07-07 French Compare
v19 2023-07-07 English Compare
v18 2023-05-27 English Compare
v17 2023-05-26 French Compare
v16 2023-05-26 English Compare
v15 2023-05-23 French Compare
v14 2023-05-23 English Compare
v13 2023-05-18 French Compare
v12 2023-05-18 English Compare
v11 2023-05-12 French Compare
v10 2023-05-12 English Compare
v9 2023-05-04 French Compare
v8 2023-05-04 English Compare
v7 2023-04-27 French Compare
v6 2023-04-27 English Compare

Showing 1 to 20 of 25